Qube Research & Technologies »

Exagen shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Exagen (XGN) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $323 204 1.59
2023-09-30 $500 204 2.45

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Johnson & Johnson Call Option (JNJ)
Oracle Corporation (ORCL)
Tesla Motors Call Option (TSLA)
Hess (HES)
McDonald's Corporation Put Option (MCD)
Amgen Call Option (AMGN)
S&p Global Call Option (SPGI)

View all positions for Qube Research & Technologies

Top funds holding Exagen

Rtw Investments
Cowen And Company
Daniel D. Thurber
Silvercrest Asset Management Group
Perkins Capital Management
Vanguard Group
Morgan Stanley
Stonepine Capital Management
Geode Capital Management
Penbrook Managment
Nantahala Capital Management
UBS Group
BlackRock
Renaissance Technologies
Bridgeway Capital Management

View all funds holding Exagen